148 related articles for article (PubMed ID: 22975565)
1. Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Kitada M; Suzuki H; Ichihashi J; Inada R; Miyamoto K; Takahashi T; Mitsui Y; Fujihara K; Kusunoki S
Intern Med; 2012; 51(17):2443-7. PubMed ID: 22975565
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
3. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Yaguchi H; Sakushima K; Takahashi I; Nishimura H; Yashima-Yamada M; Nakamura M; Tsuzaka K; Maruo Y; Takahashi T; Yabe I; Sasaki H
Intern Med; 2013; 52(9):969-72. PubMed ID: 23648715
[TBL] [Abstract][Full Text] [Related]
5. A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster.
Park JS; Hwang SJ; Shin JH; Kim DS
J Neurol Sci; 2013 Nov; 334(1-2):69-71. PubMed ID: 23953947
[TBL] [Abstract][Full Text] [Related]
6. Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Wang L; Su HJ; Qi JL; E RF; Zhao K
J Int Med Res; 2018 Aug; 46(8):3411-3416. PubMed ID: 29806512
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
8. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
11. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
12. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
13. Intractable axonal neuropathy with multifocal peripheral nerve swelling in neuromyelitis optica spectrum disorders: A case report.
Mizuno Y; Shinoda K; Watanabe M; Ogata H; Isobe N; Matsushita T; Yamasaki R; Tanaka K; Koike H; Katsuno M; Kira JI
Mult Scler Relat Disord; 2019 Oct; 35():16-18. PubMed ID: 31279231
[TBL] [Abstract][Full Text] [Related]
14. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level.
Nishimura H; Enokida H; Sakamoto T; Takahashi T; Hayami H; Nakagawa M
J Artif Organs; 2018 Sep; 21(3):378-382. PubMed ID: 29675599
[TBL] [Abstract][Full Text] [Related]
16. Influenza-associated monophasic neuromyelitis optica.
Nakamura Y; Ikeda K; Yoshii Y; Ito H; Hirayama T; Kawabe K; Kano O; Iwasaki Y
Intern Med; 2011; 50(15):1605-9. PubMed ID: 21804290
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis.
Muroishi T; Sakai K; Yanase D; Ikeda Y; Machiya T; Kato-Motozaki Y; Samuraki M; Yamada M
J Clin Neurosci; 2018 Feb; 48():93-94. PubMed ID: 29137920
[TBL] [Abstract][Full Text] [Related]
20. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
Ungureanu A; de Seze J; Ahle G; Sellal F
Rev Neurol (Paris); 2018 Dec; 174(10):675-679. PubMed ID: 30293882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
